NVS Crosses Above Average Analyst Target
January 25, 2018 at 09:42 AM EST
In recent trading, shares of Novartis AG Basel (NVS) have crossed above the average analyst 12-month target price of $90.75, changing hands for $91.44/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..